Navigation Links
Potential Nipah vaccine passes primate test

Researchers have successfully tested a vaccine for the deadly Nipah virus in monkeys, raising hopes that it could provide similar protection for humans.

With greater than a 75 percent fatality rate and the ability to be transmitted directly from person to person, Nipah has long been a significant concern for infectious-disease experts. The virus, which is carried naturally by fruit bats, was first discovered in Malaysia in 1998. Outbreaks have occurred in nearly every year since, in Singapore, Bangladesh and India.

"This vaccine is based on a protein from Hendra virus, which is a very close relative of Nipah Hendra's found in Australia and is also spread by bats, which give it to horses, which give it to people," said University of Texas Medical Branch at Galveston professor Thomas Geisbert, senior author of a paper on the study now online in Science Translational Medicine. "We've got a lot of confidence that the vaccine will work in people, because the animal model we used in this experiment, the African green monkey, faithfully reproduces all aspects of human Nipah and Hendra disease."

Because there is no approved vaccine or therapy for Nipah, the researchers conducted their study in a biosafety level 4 "spacesuit" facility at the National Institutes of Health's Rocky Mountain Laboratories in Hamilton, Mont. There, the scientists divided nine monkeys into three equal groups, administering a different vaccine dose to each group.

Forty-two days later, the researchers infected the animals with what should have been a lethal dose of Nipah. But all of the vaccinated monkeys even those that had received the lowest dose of the vaccine remained completely healthy.

"The vaccine worked great," Geisbert said.

The researchers plan further studies to prepare for a possible application for review by the Food and Drug Administration to license the vaccine for human use. In addition, the vaccine is now in commercial development in Australia to protect horses from Hendra virus.

Contact: Jim Kelly
University of Texas Medical Branch at Galveston

Related medicine news :

1. Researchers find potential cancer roadblock
2. Early treatment could mean greater earning potential for people with HIV
3. Rejected Alzheimers drug shows new potential
4. ACR: Medical imaging study in health affairs incomplete and potentially misleading
5. Texas A&M biologists prove ZOLOFT packs potential to fight fungal meningitis
6. Researchers study vaccine as potential weapon against aggressive brain tumors
7. Research shows potential of microneedles to target therapeutics to the back of the eye
8. Moffitt Cancer Center researchers find potential key to new treatment for mantle cell lymphoma
9. Beige Fat Joins Brown Fat as Potential Weight-Loss Target
10. Regulation by proteins outside cancer cells points to potential new drug target
11. BUSM in vitro study identifies potential combination therapy for breast cancer
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: